[ConservativeMind]

From the study abstract, Ozempic (also known as semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA)) had a hazard ratio of 2.81 versus sodium-glucose co-transporter 2 inhibitors (SGLT-2is) like Jardiance, Farxiga, or Brenzavvy.

The absolute risk was still quite low for Ozempic-type drugs, with an apparent increase of 1.41 people affected over 10,000 use years.

Do note there appears to be a likely reason for why Ozempic-type drugs are more inclined to do this, so keep this in mind when looking to use these weight loss drugs.

[ConservativeMind]

The “Take Charge Of Your Health” Ping List
This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.

Email me to get on either the “Common/Top Issues” (20 - 25% fewer pings) or “Everything” list.

[ConjunctionJunction]

This happened to a close friend. She has lost about 40% of her vision.

[Delta 21]

New Wonder drug for weight loss, one eye at a time!

[tired&retired]

I would expect that it also causes hypoxia and drusen to form, resulting in macular degeneration.

[ducttape45]

I’ll bet a lot more side effects associated with this drug will surface soon.

[metmom]

And I’ll bet that’s just the beginning of what is going to show up.

[steve86]

“keep this in mind when looking to use these weight loss drugs.”

Increased risk when T2D is present but what about when it is not?